Paving the Way for Advanced Therapies
This article was originally published in RAJ Devices
Executive Summary
The new EU advanced therapies legislation will introduce a new regulatory review procedure with important implications for both drug and device companies. Ian Schofield reports from a meeting in London on the likely effects of the changes